Austin psychiatrist Dr. Donald J. Garcia is enrolling patients in a study on a new kind of medication for major depressive ...

The phase III X-TOLE2 and X-TOLE3 trials in focal-onset seizures are ongoing, with the first topline data readout anticipated ...

Discover why bipolar disorder manifests uniquely in each person through different subtypes, episode patterns, and biological ...

A study published in the Psychological Medicine journal emphasised a lesser-known effect of major depressive disorder: it may ...

Largo, FL – Clean Recovery Centers is a local rehab and mental health facility that recently published an article diving into ...

Almost all the patients with depression who received Gilgamesh Pharmaceuticals’ psychedelic drug candidate went into ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, was featured in a poster ...

Mindfulness-based cognitive therapy can offer significant relief from depressive symptoms that don’t remit after ...

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent ...

Mood swings can occur during a migraine attack during the prodrome, headache, and postdrome phases. But people with migraine ...

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...